More than two dozen hospital trusts publicly listed by NHS England as benefiting from Palantir’s £330 million Federated Data Platform (FDP) are not using all or most of the system, according to Freedom of Information requests obtained by charity Medact and reported by the Guardian. Out of 137 trusts stated as ’live’ by NHS England, 29 responded that the FDP is not live, they are not using its applications, or they have no implementation timeline agreed.
The findings have drawn sharp criticism from senior health officials and MPs, who describe the claims as misleading and call for the government to exercise a 2027 break clause in Palantir’s contract. The scrutiny follows prior investigations by the Office for Statistics Regulation regarding NHS England’s claims about the platform’s impact on operation volume. Palantir UK and Europe CEO Louis Mosley defended the contract, stating that terminating the deal would put politics above patients.
Why it matters
Highlights severe adoption bottlenecks and public relations risks for enterprise AI vendors selling into large public sector health systems.
Demonstrates growing political and regulatory scrutiny over health data platform metrics, vendor procurement, and contract enforcement.
Signals potential opportunity for UK-native suppliers as lawmakers push for open, locally hosted alternatives to US tech vendors.
Source: theguardian.com



